Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2009: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Research Abstract |
Several studies have reported that activation of LXR is atheroprotective; however, the role of LXR in renal function remains unclear. Here, we report the renoprotective effects of LXR activation in a model of streptozotocin-induced diabetic nephropathy. These findings uncover a previously unrecognized mechanism for the renoprotective effects of LXR agonists and support the concept that LXR agonists may offer a novel therapeutic approach for the treatment of diabetic nephropathy.
|